Attached files

file filename
8-K - 8-K - SCHULMAN A INCshlm170628pressrelease.htm

Exhibit 99.1
image0a01.jpg

A. Schulman Reports Fiscal 2017 Third-Quarter Results

Strong performance in Asia-Pacific, Latin America and Engineered Composites offset by continued consolidation efforts in the United States and Canada region and a temporary hesitation of sales in Europe
On GAAP basis, earnings per diluted share were $0.47 compared with $0.53 in fiscal 2016 third quarter; adjusted earnings per diluted share were $0.63 compared with $0.79 in fiscal 2016 third quarter;
Fiscal 2017 third quarter adjusted earnings per diluted share of $0.63 includes the negative effect of foreign currency of $0.04 compared with last year;
Reported sales were $645.8 million; excluding the negative impact of foreign currency, sales rose 1.8 percent over the prior year period.

AKRON, Ohio - June 28, 2017 - A. Schulman, Inc. (Nasdaq: SHLM) today announced earnings for the quarter ended May 31, 2017 of $0.47 per diluted share, compared with $0.53 per diluted share in the prior year period. On an adjusted basis, reported earnings per share were $0.63 in the third quarter of fiscal 2017, compared with $0.79 in the third quarter of fiscal 2016. The fiscal 2017 third quarter adjusted earnings per diluted share of $0.63 includes the negative effect of foreign currency of $0.04 over the prior year period.

Joseph M. Gingo, chairman, president and chief executive officer stated, “I am very pleased with our strong performance in Asia-Pacific, Latin America and Engineered Composites. Our consolidated results were largely influenced by two factors. In our U.S and Canada region, while operations improved, our sales and profitability are still hampered by the complexity of the business consolidation in Evansville, Indiana. In Europe, a significant mid-quarter drop in polyolefin raw material prices interrupted our sales cycle and adversely impacted profitability. We have seen our sales cycle normalize in May and continue into June.”

Consolidated net sales for the fiscal 2017 third quarter were $645.8 million, compared with $650.4 million in the same prior-year quarter. Excluding the negative impact of foreign currency translation in the third quarter of fiscal 2017 of $16.3 million, net sales rose 1.8 percent from a year ago.

GAAP operating income in the third quarter of fiscal 2017 was $32.2 million, compared with $31.6 million in the prior year period. Adjusted operating income margin was 5.7 percent in the third quarter of fiscal 2017, compared with 7 percent in the third quarter of fiscal 2016. On a year-to-date basis, the adjusted operating margin was 5.5 percent compared with 5.9 percent in the prior year.

Net income in the fiscal 2017 third quarter was $13.9 million, compared with $15.5 million in the year-ago period. On an adjusted basis, net income for the third quarter of fiscal 2017 was $18.5 million, compared with $25.2 million in the prior year period. Fiscal 2017 third-quarter adjusted EBITDA was $56 million, compared with $66.9 million in the third quarter of fiscal 2016. 








Cash Flow/Debt Reduction
Cash provided from operations was $73.6 million in the nine months ended May 31, 2017. During the quarter, the Company reduced its net debt position by $20.3 million to a balance of $880.4 million as of May 31, 2017. Net leverage at the end of the third quarter of fiscal 2017 was 4.13x.

Business Update and Outlook
Gingo stated, “Currency translation, although improving, is a continuing headwind. If the dollar stays at the end-of-May level for the duration of the fourth quarter this would further impact the Company’s earnings by as much as two cents in the quarter and would result in 12 cents for currency impact compared with the Company’s guidance for the full fiscal year.

“With the return to a more normal sales pattern in Europe and strong performances in Latin America, Asia-Pacific and Engineered Composites, we foresee stronger year-over-year performance in our fiscal 2017 fourth quarter as we anticipate operational improvement in the U.S. and Canada region. Therefore, excluding the potential 2017 currency translation as noted above, we are maintaining our initial fiscal 2017 guidance of $2.5 billion to $2.6 billion in sales, adjusted EBITDA of $225 million to $230 million, adjusted earnings per diluted share in the range of $2.08 to $2.18 on an operating basis. Likewise, we continue to expect to achieve a return on invested capital of 11 percent to 12.5 percent in fiscal 2017.

“The trends that are starting to take shape in the fourth quarter are encouraging and will create added momentum as we progress into fiscal 2018,” he said.

Please refer to the reconciliation of GAAP and Non-GAAP financial measures for the types of items excluded from the Company’s business outlook.

Conference Call on the Web
A live Internet broadcast of A. Schulman’s conference call regarding fiscal 2017 third-quarter earnings can be accessed at 10:00 a.m. Eastern Time on June 29, 2017, on the Company’s website, www.aschulman.com. An archived replay of the call will also be available on the website.

Investor Presentation Materials
Senior executives of the Company may participate in meetings with analysts and investors throughout the fiscal year. The Company has posted presentation materials, portions of which may be used during such meetings, in the Investors section of its website at www.aschulman.com. The presentation will remain on the website as long as it is in use.

About A. Schulman, Inc.
A. Schulman, Inc. is a leading international supplier of high-performance plastic compounds and resins headquartered in Akron, Ohio. Since 1928, the Company has been providing innovative solutions to meet its customers’ demanding requirements. The Company’s customers span a wide range of markets such as packaging, mobility, building & construction, electronics & electrical, agriculture, personal care & hygiene, sports, leisure & home, custom services and others. The Company employs approximately 4,900 people and has 53 manufacturing facilities globally. A. Schulman reported net sales of approximately $2.5 billion for the fiscal year ended August 31, 2016. Additional information about A. Schulman can be found at www.aschulman.com.

Use of Non-GAAP Financial Measures
This release includes certain financial information determined by methods other than in accordance with accounting principles generally accepted in the United States (“GAAP”). These non-GAAP financial measures include segment gross profit, SG&A expenses excluding certain items, segment operating income, operating income before certain items, net income excluding certain items, net income per diluted share excluding certain items and adjusted EBITDA, as discussed further in the Reconciliation of GAAP and Non-GAAP Financial Measures below. These non-GAAP financial measures are considered




relevant to aid analysis and understanding of the Company’s results and business trends. However, non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures, and tables included in this release reconcile each non-GAAP financial measure with the most directly comparable GAAP financial measure. The most directly comparable GAAP financial measures for these purposes are gross profit, SG&A expenses, operating income, net income and net income per diluted share. The Company’s non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures, and should be read only in conjunction with the Company’s consolidated financial statements prepared in accordance with GAAP.
While the Company believes that these non-GAAP financial measures provide useful supplemental information to investors, there are very significant limitations associated with their use. These non-GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company’s competitors and may not be directly comparable to similarly titled measures of the Company’s competitors due to potential differences in the exact method of calculation. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by reviewing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures.
Cautionary Statements
A number of the matters discussed in this document that are not historical or current facts deal with potential future circumstances and developments and may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historic or current facts and relate to future events and expectations. Forward-looking statements contain such words as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which management is unable to predict or control, that may cause actual results, performance or achievements to differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements, and that could adversely affect the Company’s future financial performance, include, but are not limited to, the following:
 
worldwide and regional economic, business and political conditions, including continuing economic uncertainties in some or all of the Company’s major product markets or countries where the Company has operations;
the effectiveness of the Company’s efforts to improve operating margins through sales growth, price increases, productivity gains, and improved purchasing techniques;
competitive factors, including intense price competition;
fluctuations in the value of currencies in areas where the Company operates;
volatility of prices and availability of the supply of energy and raw materials that are critical to the manufacture of the Company’s products, particularly plastic resins derived from oil and natural gas;
changes in customer demand and requirements;
effectiveness of the Company to achieve the level of cost savings, productivity improvements, growth and other benefits anticipated from acquisitions and the integration thereof, joint ventures and restructuring initiatives;
escalation in the cost of providing employee health care;
uncertainties regarding the resolution of pending and future litigation and other claims;
the performance of the global automotive market as well as other markets served;
further adverse changes in economic or industry conditions, including global supply and demand conditions and prices for products;
operating problems with our information systems as a result of system security failures such as viruses, cyber-attacks or other causes;
our current debt position could adversely affect our financial health and prevent us from fulfilling our financial obligations; and
failure of counterparties to perform under the terms and conditions of contractual arrangements, including suppliers, customers, buyers and sellers of a business and other third parties with which the Company contracts.
    
The risks and uncertainties identified above are not the only risks the Company faces. Additional risk factors that could affect the Company’s performance are set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2016. In addition, risks and uncertainties not presently known to the Company or that it believes to be immaterial also may adversely affect the Company. Should any known or unknown risks or uncertainties develop into actual events, or underlying assumptions prove inaccurate, these developments could have material adverse effects on the Company’s business, financial condition and results of operations.






# # #
SHLM_ALL


Contact
Jennifer K. Beeman
Vice President, Corporate Communications & Investor Relations
A. Schulman, Inc.
3637 Ridgewood Road
Fairlawn, Ohio 44333
Tel: 330-668-7346
Email: Jennifer.Beeman@aschulman.com
www.aschulman.com













A. SCHULMAN, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
Three months ended May 31,
 
Nine months ended May 31,
 
2017
 
2016
 
2017
 
2016
 
(In thousands, except per share data)
Net sales
$
645,795

 
$
650,439

 
$
1,814,473

 
$
1,891,419

Cost of sales
547,368

 
540,965

 
1,525,845

 
1,587,192

Selling, general and administrative expenses
65,266

 
73,641

 
203,608

 
222,482

Restructuring expense
939

 
4,245

 
12,361

 
8,005

Operating income (loss)
32,222

 
31,588

 
72,659

 
73,740

Interest expense
13,179

 
13,557

 
39,450

 
40,965

Foreign currency transaction (gains) losses
(68
)
 
392

 
1,575

 
2,071

Other (income) expense, net
(682
)
 
(311
)
 
(1,138
)
 
(529
)
Income (loss) before taxes
19,793

 
17,950

 
32,772

 
31,233

Provision (benefit) for U.S. and foreign income taxes
3,695

 
312

 
8,157

 
4,076

Net income (loss)
16,098

 
17,638

 
24,615

 
27,157

Noncontrolling interests
(320
)
 
(241
)
 
(868
)
 
(1,075
)
Net income (loss) attributable to A. Schulman, Inc.
15,778

 
17,397

 
23,747

 
26,082

Convertible special stock dividends
1,875

 
1,875

 
5,625

 
5,625

Net income (loss) available to A. Schulman, Inc. common stockholders
$
13,903

 
$
15,522

 
$
18,122

 
$
20,457

 
 
 
 
 
 
 
 
Weighted-average number of shares outstanding:
 
 
 
 
 
 
 
Basic
29,421

 
29,339

 
29,392

 
29,284

Diluted
29,530

 
29,474

 
29,496

 
29,459

 
 
 
 
 
 
 
 
Net income (loss) per common share available to A. Schulman, Inc. common stockholders
 
 
 
 
 
 
 
Basic
$
0.47

 
$
0.53

 
$
0.62

 
$
0.70

Diluted
$
0.47

 
$
0.53

 
$
0.61

 
$
0.69

 
 
 
 
 
 
 
 
Cash dividends per common share
$
0.205

 
$
0.205

 
$
0.615

 
$
0.615

Cash dividends per share of convertible special stock
$
15.00

 
$
15.00

 
$
45.00

 
$
45.00








A. SCHULMAN, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
 
May 31,
2017
 
August 31,
2016
 
(In thousands)
ASSETS
Current assets:
 
 
 
Cash and cash equivalents
$
50,130

 
$
35,260

Restricted cash
1,068

 
8,143

Accounts receivable, less allowance for doubtful accounts of $10,415 at May 31, 2017 and $11,341 at August 31, 2016
411,004

 
376,786

Inventories
297,104

 
263,617

Prepaid expenses and other current assets
38,783

 
40,263

Assets held for sale
6,586

 

Total current assets
804,675

 
724,069

Property, plant and equipment, at cost:
 
 
 
Land and improvements
31,218

 
32,957

Buildings and leasehold improvements
177,468

 
184,291

Machinery and equipment
450,250

 
447,932

Furniture and fixtures
34,361

 
34,457

Construction in progress
28,674

 
20,431

Gross property, plant and equipment
721,971

 
720,068

Accumulated depreciation
425,486

 
405,246

Net property, plant and equipment
296,485

 
314,822

Deferred charges and other noncurrent assets
87,141

 
88,161

Goodwill
260,768

 
257,773

Intangible assets, net
338,304

 
362,614

Total assets
$
1,787,373

 
$
1,747,439

LIABILITIES AND EQUITY
Current liabilities:
 
 
 
Accounts payable
$
339,566

 
$
280,060

U.S. and foreign income taxes payable
3,783

 
8,985

Accrued payroll, taxes and related benefits
44,458

 
47,569

Other accrued liabilities
69,661

 
67,704

Short-term debt
21,453

 
25,447

Total current liabilities
478,921

 
429,765

Long-term debt
910,132

 
919,349

Pension plans
147,017

 
145,108

Deferred income taxes
49,873

 
59,013

Other long-term liabilities
24,270

 
25,844

Total liabilities
1,610,213

 
1,579,079

Commitments and contingencies
 
 
 
Stockholders’ equity:
 
 
 
Convertible special stock, no par value
120,289

 
120,289

Common stock, $1 par value, authorized - 75,000 shares, issued - 48,529 shares at May 31, 2017 and 48,510 shares at August 31, 2016
48,529

 
48,510

Additional paid-in capital
277,867

 
275,115

Accumulated other comprehensive income (loss)
(115,501
)
 
(120,721
)
Retained earnings
219,032

 
219,039

Treasury stock, at cost, 19,064 shares at May 31, 2017 and 19,069 shares at August 31, 2016
(382,871
)
 
(382,963
)
Total A. Schulman, Inc.’s stockholders’ equity
167,345

 
159,269

Noncontrolling interests
9,815

 
9,091

Total equity
177,160

 
168,360

Total liabilities and equity
$
1,787,373

 
$
1,747,439






A. SCHULMAN, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
Nine months ended May 31,
 
2017
 
2016
 
(In thousands)
Operating activities:
 
 
 
Net income
$
24,615

 
$
27,157

Adjustments to reconcile net income to net cash provided from (used in) operating activities:
 
 
 
Depreciation
32,455

 
37,347

Amortization
26,381

 
30,163

Deferred tax provision (benefit)
(9,539
)
 
(2,395
)
Pension, postretirement benefits and other compensation
5,302

 
3,161

Changes in assets and liabilities, net of acquisitions:
 
 
 
Accounts receivable
(32,841
)
 
2,574

Inventories
(32,694
)
 
19,900

Accounts payable
64,795

 
(8,145
)
Income taxes
(5,122
)
 
(9,955
)
Accrued payroll and other accrued liabilities
(1,131
)
 
2,583

Other assets and long-term liabilities
1,345

 
(6,718
)
Net cash provided from (used in) operating activities
73,566

 
95,672

Investing activities
 
 
 
Expenditures for property, plant and equipment
(30,719
)
 
(34,618
)
Proceeds from the sale of assets
2,750

 
1,184

Other investing activities
125

 

Net cash provided from (used in) investing activities
(27,844
)
 
(33,434
)
Financing activities:
 
 
 
Cash dividends paid to special stockholders
(5,625
)
 
(5,625
)
Cash dividends paid to common stockholders
(18,129
)
 
(18,012
)
Increase (decrease) in short-term debt
(2,283
)
 
2,780

Borrowings on revolving credit facility
283,943

 
124,671

Repayments of revolving credit facility
(228,973
)
 
(112,470
)
Repayments of other long-term debt and capital leases
(66,735
)
 
(97,978
)
Noncontrolling interests' distributions
(53
)
 

Issuances of stock, common and treasury
143

 
213

Redemptions of common stock
(711
)
 
(1,077
)
Purchases of treasury stock

 

Net cash provided from (used in) financing activities
(38,423
)
 
(107,498
)
Effect of exchange rate changes on cash
496

 
(2,186
)
Net increase (decrease) in cash, cash equivalents, and restricted cash
7,795

 
(47,446
)
Cash, cash equivalents, and restricted cash at beginning of period
43,403

 
96,872

Cash, cash equivalents, and restricted cash at end of period
$
51,198

 
$
49,426

 
 
 
 
Cash and cash equivalents
$
50,130

 
$
47,019

Restricted cash
1,068

 
2,407

Total cash, cash equivalents, and restricted cash
$
51,198

 
$
49,426





A. SCHULMAN, INC.
Reconciliation of GAAP and Non-GAAP Financial Measures
Unaudited
Three months ended May 31, 2017
 
Cost of Sales
 
Gross Margin
 
SG&A
 
Restructuring Expense
 
Operating Income
 
Non Operating (Income) Expense
 
Income Tax Expense (Benefit)
 
Net Income Available to ASI Common Stockholders
 
Diluted EPS
29,530

 
(In thousands, except for %'s and per share data)
As reported
 
$
547,368

 
15.2
%
 
$
65,266

 
$
939

 
$
32,222

 
$
12,429

 
$
3,695

 
$
13,903

 
$
0.47

Certain items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accelerated depreciation (1)
 
(236
)
 
 
 
(1
)
 

 
237

 

 
49

 
188

 
0.01

Restructuring and related costs (3)
 

 
 
 
(1,993
)
 
(939
)
 
2,932

 

 
604

 
2,328

 
0.07

Lucent costs (4)
 
(104
)
 
 
 
(1,626
)
 

 
1,730

 

 
356

 
1,374

 
0.05

Tax (benefits) charges (7)
 

 
 
 

 

 

 

 
(890
)
 
890

 
0.03

Gain on asset sale (10)
 
 
 
 
 
 
 
 
 

 
169

 
(35
)
 
(134
)
 

Total certain items
 
(340
)
 
0.1
%
 
(3,620
)
 
(939
)
 
4,899

 
169

 
84

 
4,646

 
0.16

As Adjusted
 
$
547,028

 
15.3
%
 
$
61,646

 
$

 
$
37,121

 
$
12,598

 
$
3,779

 
$
18,549

 
$
0.63

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage of Revenue
 
 
 
 
 
9.5
%
 
 
 
5.7
%
 
 
 
 
 
2.9
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective Tax Rate
 
 
 
 
 
 
 
 
 
 
 
 
 
15.4
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended May 31, 2016
 
Cost of Sales
 
Gross Margin
 
SG&A
 
Restructuring Expense
 
Operating Income
 
Non Operating (Income) Expense
 
Income Tax Expense (Benefit)
 
Net Income Available to ASI Common Stockholders
 
Diluted EPS
31,863

 
(In thousands, except for %'s and per share data)
As reported
 
$
540,965

 
16.8
%
 
$
73,641

 
$
4,245

 
$
31,588

 
$
13,638

 
$
312

 
$
15,522

 
$
0.53

Convertible special stock dividends (9)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,875

 
0.03

Certain items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accelerated depreciation (1)
 
(1,283
)
 
 
 
(3
)
 

 
1,286

 

 
243

 
1,043

 
0.03

Costs related to acquisitions and integrations (2)
 
(423
)
 
 
 
(1,020
)
 

 
1,443

 

 
235

 
1,208

 
0.04

Restructuring and related costs (3)
 
(1,647
)
 
 
 
(3,628
)
 
(4,245
)
 
9,520

 
(127
)
 
2,099

 
7,548

 
0.23

Lucent costs (4)
 
(466
)
 
 
 
(1,485
)
 

 
1,951

 

 
385

 
1,566

 
0.05

Accelerated amortization of debt issuance costs (6)
 

 

 

 

 

 
(163
)
 
34

 
129

 

Tax (benefits) charges (7)
 

 

 

 

 

 

 
3,664

 
(3,664
)
 
(0.12
)
Total certain items
 
(3,819
)
 
0.6
%
 
(6,136
)
 
(4,245
)
 
14,200

 
(290
)
 
6,660

 
9,705

 
0.26

As Adjusted
 
$
537,146

 
17.4
%
 
$
67,505

 
$

 
$
45,788

 
$
13,348

 
$
6,972

 
$
25,227

 
$
0.79

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage of Revenue
 
 
 
 
 
10.4
%
 
 
 
7.0
%
 
 
 

 
3.9
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective Tax Rate
 
 
 
 
 
 
 
 
 
 
 
 
 
21.5
%
 
 
 
 




Nine months ended May 31, 2017
 
Cost of Sales
 
Gross Margin
 
SG&A
 
Restructuring Expense
 
Operating Income
 
Non Operating (Income) Expense
 
Income Tax Expense (Benefit)
 
Net Income Available to ASI Common Stockholders
 
Diluted EPS
29,496

 
(In thousands, except for %'s and per share data)
As reported
 
$
1,525,845

 
15.9
%
 
$
203,608

 
$
12,361

 
$
72,659

 
$
39,887

 
$
8,157

 
$
18,122

 
$
0.61

Certain items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset impairment (8)
 

 
 
 
(678
)
 

 
678

 
(1,623
)
 
474

 
1,827

 
0.06

Accelerated depreciation (1)
 
(1,059
)
 
 
 
(1
)
 

 
1,060

 

 
218

 
842

 
0.03

Costs related to acquisitions and integrations (2)
 
(57
)
 
 
 
(548
)
 

 
605

 

 
125

 
480

 
0.02

Restructuring and related costs (3)
 
(1,042
)
 
 
 
(7,773
)
 
(12,361
)
 
21,176

 

 
4,362

 
16,814

 
0.56

Lucent costs (4)
 
(190
)
 
 
 
(2,945
)
 

 
3,135

 

 
646

 
2,489

 
0.08

CEO transition costs (5)
 

 
 
 
(196
)
 

 
196

 

 
40

 
156

 
0.01

Accelerated amortization of debt issuance costs (6)
 

 
 
 

 

 

 
(227
)
 
47

 
180

 
0.01

Tax (benefits) charges (7)
 

 
 
 

 

 

 

 
(1,428
)
 
1,428

 
0.05

Gain on asset sale (10)
 

 
 
 

 

 

 
169

 
(35
)
 
(134
)
 

Total certain items
 
(2,348
)
 
0.1
%
 
(12,141
)
 
(12,361
)
 
26,850

 
(1,681
)
 
4,449

 
24,082

 
0.82

As Adjusted
 
$
1,523,497

 
16.0
%
 
$
191,467

 
$

 
$
99,509

 
$
38,206

 
$
12,606

 
$
42,204

 
$
1.43

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage of Revenue
 
 
 
 
 
10.6
%
 
 
 
5.5
%
 
 
 
 
 
2.3
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective Tax Rate
 
 
 
 
 
 
 
 
 
 
 
 
 
20.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine months ended May 31, 2016
 
Cost of Sales
 
Gross Margin
 
SG&A
 
Restructuring Expense
 
Operating Income
 
Non Operating (Income) Expense
 
Income Tax Expense (Benefit)
 
Net Income Available to ASI Common Stockholders
 
Diluted EPS
29,459

 
(In thousands, except for %'s and per share data)
As reported
 
$
1,587,192

 
16.1
%
 
$
222,482

 
$
8,005

 
$
73,740

 
$
42,507

 
$
4,076

 
$
20,457

 
$
0.69

Certain items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accelerated depreciation (1)
 
(4,779
)
 
 
 
(17
)
 

 
4,796

 

 
1,127

 
3,669

 
0.12

Costs related to acquisitions and integrations (2)
 
(2,522
)
 
 
 
(5,048
)
 

 
7,570

 

 
1,779

 
5,791

 
0.19

Restructuring and related costs (3)
 
(2,532
)
 
 
 
(9,422
)
 
(8,005
)
 
19,959

 
(488
)
 
4,872

 
15,575

 
0.54

Lucent costs (4)
 
(1,844
)
 
 
 
(4,424
)
 

 
6,268

 

 
1,473

 
4,795

 
0.17

Accelerated amortization of debt issuance costs (6)
 

 
 
 

 

 

 
(437
)
 
103

 
334

 
0.01

Tax (benefits) charges (7)
 

 
 
 

 

 

 

 
3,197

 
(3,197
)
 
(0.11
)
Total certain items
 
(11,677
)
 
0.6
%
 
(18,911
)
 
(8,005
)
 
38,593

 
(925
)
 
12,551

 
26,967

 
0.92

As Adjusted
 
$
1,575,515

 
16.7
%
 
$
203,571

 
$

 
$
112,333

 
$
41,582

 
$
16,627

 
$
47,424

 
$
1.61

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage of Revenue
 
 
 
 
 
10.8
%
 
 
 
5.9
%
 
 
 

 
2.5
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective Tax Rate
 
 
 
 
 
 
 
 
 
 
 
 
 
23.5
%
 
 
 
 

1 - Accelerated depreciation is related to restructuring plans in the Company's USCAN and EMEA segments.




2 - Costs related to acquisitions and integrations primarily include third party professional, legal, IT and other expenses associated with successful and unsuccessful full or partial acquisition and divestiture/dissolution transactions, as well as certain employee-related expenses such as travel, one-time bonuses and post-acquisition severance separate from a formal restructuring plan.
3 - Restructuring and related costs include items such as employee severance charges, lease termination charges, curtailment gains/losses, other employee termination costs and charges related to the reorganization of the legal entity structure. Refer to Note 12 in the Company's Quarterly Report on Form 10-Q for further discussion.
4 - Lucent costs primarily represent legal and investigation costs related to resolving the Lucent matter, product manufacturing costs for reworking existing Lucent inventory, obsolete Lucent inventory reserve costs, and dedicated internal personnel costs that would have otherwise been focused on normal operations.
5 - CEO transition costs represent charges for deferred compensation granted to Bernard Rzepka.
6 - Write off of debt issuance costs are related to prepayments of $56.0 million of Term Loan B. Refer to Note 3 in the Company's Quarterly Report on Form 10-Q for further discussion.
7 - Tax (benefits) charges represent the Company's quarterly non-GAAP tax based on the overall estimated annual non-GAAP effective tax rates.
8 - Asset impairment relates to the discontinuation of information technology assets in the USCAN segment and future cash settlement of a commitment to a local government.
9 - Convertible special stock dividends have been added back as the 2.4 million shares of convertible special stock were considered dilutive to the third quarter of fiscal 2016.
10 - Gain related to sale of assets that had previously been classified as held for sale.




A. SCHULMAN, INC.
ADJUSTED EBITDA RECONCILIATION
(Unaudited)
 
Three months ended May 31,
 
Nine months ended May 31,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
 
 
 
 
 
 
 
 
Net income available to A. Schulman, Inc. common stockholders
$
13,903

 
$
15,522

 
$
18,122

 
$
20,457

     Interest expense
13,179

 
13,557

 
39,450

 
40,965

     Provision for U.S. and foreign income taxes
3,695

 
312

 
8,157

 
4,076

     Depreciation and amortization
18,977

 
22,409

 
58,836

 
67,510

     Noncontrolling interests
320

 
241

 
868

 
1,075

     Convertible special stock dividends
1,875

 
1,875

 
5,625

 
5,625

     Other (1)
(750
)
 
163

 
437

 
1,825

EBITDA, as calculated
$
51,199

 
$
54,079

 
$
131,495

 
$
141,533

     Non-GAAP Adjustments (2)
4,765

 
12,832

 
25,790

 
33,501

EBITDA, as adjusted
$
55,964

 
$
66,911

 
$
157,285

 
$
175,034

 
 
 
 
 
 
 
 

(1) - Other includes Foreign currency transaction (gains) losses and Other (income) expense, net.

(2) - For details on Non-GAAP adjustments, refer to "Reconciliation of GAAP and Non-GAAP Financial Measures", items (2) - (8). Amounts are included in Operating Income. Accelerated depreciation on the "Reconciliation of GAAP and Non-GAAP Financial Measures" has been excluded as it is already included in Depreciation and amortization above. The three months ended May 31, 2017 exclude additional depreciation expense which is in restructuring and related costs as it has already been included in Depreciation and amortization above. The nine months ended May 31, 2016 also include additional amortization expense which is in SG&A in the "Reconciliation of GAAP and Non-GAAP Financial Measures". This expense has been added back to adjusted EBITDA.







A. SCHULMAN, INC.
SUPPLEMENTAL SEGMENT INFORMATION
(Unaudited)
 
 
Net Sales
 
Net Sales
 
 
Three months ended May 31,
 
Nine months ended May 31,
EMEA
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
 
 
(In thousands, except for %'s)
Custom Concentrates and Services
 
$
174,394

 
$
177,863

 
$
(3,469
)
 
(2.0
)%
 
$
481,512

 
$
506,773

 
$
(25,261
)
 
(5.0
)%
Performance Materials
 
143,632

 
144,505

 
(873
)
 
(0.6
)%
 
409,488

 
434,021

 
(24,533
)
 
(5.7
)%
Total EMEA
 
$
318,026

 
$
322,368

 
$
(4,342
)
 
(1.3
)%
 
$
891,000

 
$
940,794

 
$
(49,794
)
 
(5.3
)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Net Sales
 
 
Three months ended May 31,
 
Nine months ended May 31,
USCAN
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
 
 
(In thousands, except for %'s)
Custom Concentrates and Services
 
$
65,613

 
$
66,841

 
$
(1,228
)
 
(1.8
)%
 
$
188,496

 
$
194,153

 
$
(5,657
)
 
(2.9
)%
Performance Materials
 
102,268

 
116,497

 
(14,229
)
 
(12.2
)%
 
287,721

 
338,284

 
(50,563
)
 
(14.9
)%
Total USCAN
 
$
167,881

 
$
183,338

 
$
(15,457
)
 
(8.4
)%
 
$
476,217

 
$
532,437

 
$
(56,220
)
 
(10.6
)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Net Sales
 
 
Three months ended May 31,
 
Nine months ended May 31,
LATAM
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
 
 
(In thousands, except for %'s)
Custom Concentrates and Services
 
$
32,396

 
$
32,156

 
$
240

 
0.7
 %
 
$
89,739

 
$
94,568

 
$
(4,829
)
 
(5.1
)%
Performance Materials
 
15,012

 
11,221

 
3,791

 
33.8
 %
 
39,547

 
32,170

 
7,377

 
22.9
 %
Total LATAM
 
$
47,408

 
$
43,377

 
$
4,031

 
9.3
 %
 
$
129,286

 
$
126,738

 
$
2,548

 
2.0
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Net Sales
 
 
Three months ended May 31,
 
Nine months ended May 31,
APAC
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
 
 
(In thousands, except for %'s)
Custom Concentrates and Services
 
$
24,514

 
$
23,531

 
$
983

 
4.2
 %
 
$
72,677

 
$
69,191

 
$
3,486

 
5.0
 %
Performance Materials
 
28,714

 
23,349

 
5,365

 
23.0
 %
 
80,202

 
68,444

 
11,758

 
17.2
 %
Total APAC
 
$
53,228

 
$
46,880

 
$
6,348

 
13.5
 %
 
$
152,879

 
$
137,635

 
$
15,244

 
11.1
 %
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Net Sales
 
 
Three months ended May 31,
 
Nine months ended May 31,
Consolidated
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
 
 
(In thousands, except for %'s)
Engineered Composites
 
$
59,252

 
$
54,476

 
$
4,776

 
8.8
 %
 
$
165,091

 
$
153,815

 
$
11,276

 
7.3
 %
Custom Concentrates and Services
 
296,917

 
300,391

 
(3,474
)
 
(1.2
)%
 
832,424

 
864,685

 
(32,261
)
 
(3.7
)%
Performance Materials
 
289,626

 
295,572

 
(5,946
)
 
(2.0
)%
 
816,958

 
872,919

 
(55,961
)
 
(6.4
)%
Total Consolidated
 
$
645,795

 
$
650,439

 
$
(4,644
)
 
(0.7
)%
 
$
1,814,473

 
$
1,891,419

 
$
(76,946
)
 
(4.1
)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 








 
 
Segment Gross Profit
 
Segment Gross Profit
 
 
Three months ended May 31,
 
Nine months ended May 31,
 
 
2017
 
2016
 
$ Change
 
% Change
 
2017
 
2016
 
$ Change
 
% Change
 
 
(In thousands, except for %'s)
 
 
 
 
 
 
 
 
EMEA
 
$
42,509

 
$
49,852

 
$
(7,343
)
 
(14.7
)%
 
$
126,297

 
$
136,489

 
$
(10,192
)
 
(7.5
)%
USCAN
 
21,844

 
32,560

 
(10,716
)
 
(32.9
)%
 
66,420

 
90,095

 
(23,675
)
 
(26.3
)%
LATAM
 
9,928

 
9,055

 
873

 
9.6
 %
 
28,940

 
27,226

 
1,714

 
6.3
 %
APAC
 
9,155

 
8,080

 
1,075

 
13.3
 %
 
27,189

 
24,153

 
3,036

 
12.6
 %
EC
 
15,331

 
13,746

 
1,585

 
11.5
 %
 
42,130

 
37,941

 
4,189

 
11.0
 %
Total segment gross profit
 
$
98,767

 
$
113,293

 
$
(14,526
)
 
(12.8
)%
 
$
290,976

 
$
315,904

 
$
(24,928
)
 
(7.9
)%
Accelerated depreciation and restructuring related costs
 
(236
)
 
(2,930
)
 
2,694

 
(91.9
)%
 
(2,101
)
 
(7,311
)
 
5,210

 
(71.3
)%
Costs related to acquisitions and integrations
 

 
(423
)
 
423

 
 %
 
(57
)
 
(2,522
)
 
2,465

 
(97.7
)%
Lucent costs (1)
 
(104
)
 
(466
)
 
362

 
 %
 
(190
)
 
(1,844
)
 
1,654

 
(89.7
)%
Total gross profit
 
$
98,427

 
$
109,474

 
$
(11,047
)
 
(10.1
)%
 
$
288,628

 
$
304,227

 
$
(15,599
)
 
(5.1
)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (1)Refer to Note 13, Commitments and Contingencies, for additional discussion on this matter. Lucent costs in cost of sales include additional product and manufacturing operational costs for reworking inventory. Lucent costs in selling, general and administrative expenses include legal and investigative costs. In addition, in the three and nine months ended May 31, 2016, Lucent costs in SG&A also include dedicated internal personnel costs that would have otherwise been focused on normal operations. 
(2)Retructuring related costs for the three and nine months ended May 31, 2017 of $2.0 million and $8.8 million, respectively, and for the three and nine months ended May 31, 2016 of $5.3 million and $12.0 million, respectively, primarily included in selling, general and administrative expenses in the Company's statements of operations, are costs associated with professional fees for outside strategic consultants regarding actions to improve the profitability of the organization and efficiency of its operations, and costs associated with reorganizations of the legal entity structure of the Company. Restructuring expenses included in restructuring expense in the Company's statement of operations include costs permitted under ASC 420, Exit or Disposal Obligations, such as severance costs, outplacement services and contract termination costs.